Operating Income Summary of Bionime Corporation

Bionime Corporation's latest annual operating income in 2023 was -13.33 Million TWD , down -109.09% from previous year.
Bionime Corporation's latest quarterly operating income in 2024 Q2 was -51.79 Million TWD , down -1400.35% from previous quarter.
Bionime Corporation reported an annual operating income of 146.71 Million TWD in 2022, up 100.78% from previous year.
Bionime Corporation reported an annual operating income of 73.07 Million TWD in 2021, down -3.78% from previous year.
Bionime Corporation reported a quarterly operating income of -3.45 Million TWD for 2024 Q1, up 83.42% from previous quarter.
Bionime Corporation reported a quarterly operating income of -2.61 Million TWD for 2023 Q3, down -156.52% from previous quarter.

Annual Operating Income Chart of Bionime Corporation (2023 - 2009)

Historical Annual Operating Income of Bionime Corporation (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	-13.33 Million TWD	-109.09%
2022	146.71 Million TWD	100.78%
2021	73.07 Million TWD	-3.78%
2020	75.94 Million TWD	-56.98%
2019	176.53 Million TWD	-26.23%
2018	239.29 Million TWD	-3.67%
2017	248.41 Million TWD	-3.86%
2016	258.4 Million TWD	36.16%
2015	189.78 Million TWD	27.11%
2014	149.3 Million TWD	3.06%
2013	144.87 Million TWD	104.44%
2012	70.86 Million TWD	-63.39%
2011	193.57 Million TWD	-3.37%
2010	200.32 Million TWD	33.42%
2009	150.15 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-51.79 Million TWD	-1400.35%
2024 Q1	-3.45 Million TWD	83.42%
2023 Q3	-2.61 Million TWD	-156.52%
2023 FY	-13.33 Million TWD	-109.09%
2023 Q1	-8.91 Million TWD	-122.98%
2023 Q4	-20.81 Million TWD	-695.53%
2023 Q2	4.63 Million TWD	151.94%
2022 Q2	49.97 Million TWD	61.72%
2022 FY	146.71 Million TWD	100.78%
2022 Q1	30.9 Million TWD	-4.21%
2022 Q3	27.04 Million TWD	-45.89%
2022 Q4	38.79 Million TWD	43.44%
2021 Q4	32.26 Million TWD	57.25%
2021 FY	73.07 Million TWD	-3.78%
2021 Q1	10.35 Million TWD	-82.25%
2021 Q2	6.73 Million TWD	-34.99%
2021 Q3	20.51 Million TWD	204.86%
2020 Q1	-8.64 Million TWD	-110.48%
2020 Q2	-24.06 Million TWD	-178.3%
2020 Q3	18.78 Million TWD	178.08%
2020 FY	75.94 Million TWD	-56.98%
2020 Q4	58.32 Million TWD	210.44%
2019 FY	176.53 Million TWD	-26.23%
2019 Q1	16.25 Million TWD	-86.75%
2019 Q2	46.1 Million TWD	183.6%
2019 Q3	21.61 Million TWD	-53.11%
2019 Q4	82.46 Million TWD	281.46%
2018 FY	239.29 Million TWD	-3.67%
2018 Q4	122.68 Million TWD	116.61%
2018 Q3	56.64 Million TWD	34.32%
2018 Q2	42.17 Million TWD	109.49%
2018 Q1	20.13 Million TWD	-78.44%
2017 Q4	93.37 Million TWD	58.38%
2017 Q3	58.96 Million TWD	-0.58%
2017 FY	248.41 Million TWD	-3.86%
2017 Q2	59.3 Million TWD	61.28%
2017 Q1	36.77 Million TWD	-65.01%
2016 FY	258.4 Million TWD	36.16%
2016 Q4	105.09 Million TWD	60.1%
2016 Q3	65.64 Million TWD	4.68%
2016 Q2	62.7 Million TWD	151.24%
2016 Q1	24.95 Million TWD	-65.38%
2015 FY	189.78 Million TWD	27.11%
2015 Q3	52.59 Million TWD	111.03%
2015 Q4	72.09 Million TWD	37.08%
2015 Q2	24.92 Million TWD	-37.95%
2015 Q1	40.16 Million TWD	-40.06%
2014 Q4	67 Million TWD	69.91%
2014 Q1	12.36 Million TWD	-71.98%
2014 Q2	30.5 Million TWD	146.76%
2014 FY	149.3 Million TWD	3.06%
2014 Q3	39.43 Million TWD	29.3%
2013 Q3	39.88 Million TWD	-4.2%
2013 Q1	19.24 Million TWD	1479.97%
2013 FY	144.87 Million TWD	104.44%
2013 Q4	44.1 Million TWD	10.57%
2013 Q2	41.63 Million TWD	116.37%
2012 Q1	10.6 Million TWD	-84.74%
2012 Q4	1.21 Million TWD	-96.86%
2012 Q3	38.83 Million TWD	187.44%
2012 Q2	13.51 Million TWD	27.45%
2012 FY	70.86 Million TWD	-63.39%
2011 Q1	32.63 Million TWD	-55.37%
2011 FY	193.57 Million TWD	-3.37%
2011 Q4	69.46 Million TWD	75.37%
2011 Q3	39.6 Million TWD	-23.64%
2011 Q2	51.86 Million TWD	58.92%
2010 Q4	73.13 Million TWD	58.96%
2010 Q2	46.56 Million TWD	34.47%
2010 Q3	46 Million TWD	-1.2%
2010 Q1	34.62 Million TWD	0.0%
2010 FY	200.32 Million TWD	33.42%
2009 FY	150.15 Million TWD	0.0%

Peer Operating Income Comparison of Bionime Corporation

Name	Operating Income	Operating Income Difference
Nang Kuang Pharmaceutical Co., Ltd.	259.91 Million TWD	105.132%
Maxigen Biotech Inc.	149.85 Million TWD	108.902%
SciVision Biotech Inc.	199.63 Million TWD	106.682%
Pegavision Corporation	1.98 Billion TWD	100.673%
Visco Vision Inc.	334.7 Million TWD	103.985%

Global Stocks Search

Bionime Corporation (4737.TW)

Operating Income Summary of Bionime Corporation

Annual Operating Income Chart of Bionime Corporation (2023 - 2009)

Historical Annual Operating Income of Bionime Corporation (2023 - 2009)

Peer Operating Income Comparison of Bionime Corporation